Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 11 2019
Historique:
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 1 2 2020
Statut: ppublish

Résumé

To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.

Identifiants

pubmed: 31725168
pii: 2755677
doi: 10.1167/iovs.19-27486
doi:

Substances chimiques

Eye Proteins 0
RP1L1 protein, human 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4691-4700

Auteurs

Natsuko Nakamura (N)

Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Department of Ophthalmology, The University of Tokyo, Tokyo, Japan.

Kazushige Tsunoda (K)

Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

Yoshinobu Mizuno (Y)

Department of Ophthalmology, Teikyo University, Tokyo, Japan.

Tomoaki Usui (T)

Akiba Eye Clinic, Niigata, Japan.

Tetsuhisa Hatase (T)

Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

Shinji Ueno (S)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Kazuki Kuniyoshi (K)

Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.

Takaaki Hayashi (T)

Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.

Satoshi Katagiri (S)

Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.

Mineo Kondo (M)

Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Shuhei Kameya (S)

Department of Ophthalmology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.

Kazutoshi Yoshitake (K)

Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

Kaoru Fujinami (K)

Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
University College London Institute of Ophthalmology, London, United Kingdom.
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Takeshi Iwata (T)

Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

Yozo Miyake (Y)

Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Kobe Eye Center, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH